201 related articles for article (PubMed ID: 27177086)
1. GADD45β induction by S-adenosylmethionine inhibits hepatocellular carcinoma cell proliferation during acute ischemia-hypoxia.
Ma D; Shen B; Seewoo V; Tong H; Yang W; Cheng X; Jin Z; Peng C; Qiu W
Oncotarget; 2016 Jun; 7(24):37215-37225. PubMed ID: 27177086
[TBL] [Abstract][Full Text] [Related]
2. The different induction mechanisms of growth arrest DNA damage inducible gene 45 β in human hepatoma cell lines.
Seewoo V; Yang W; Du H; Wang J; Lin A; Shen B; Peng C; Li H; Qiu W
Chemotherapy; 2012; 58(2):165-74. PubMed ID: 22678405
[TBL] [Abstract][Full Text] [Related]
3. The induction of growth arrest DNA damage-inducible gene 45 beta in human hepatoma cell lines by S-adenosylmethionine.
Qiu W; Zhou B; Chu PG; Luh F; Yen Y
Am J Pathol; 2007 Jul; 171(1):287-96. PubMed ID: 17591973
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma.
Qiu W; David D; Zhou B; Chu PG; Zhang B; Wu M; Xiao J; Han T; Zhu Z; Wang T; Liu X; Lopez R; Frankel P; Jong A; Yen Y
Am J Pathol; 2003 Jun; 162(6):1961-74. PubMed ID: 12759252
[TBL] [Abstract][Full Text] [Related]
6. Induction of DNA damage-inducible gene GADD45beta contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells.
Ou DL; Shen YC; Yu SL; Chen KF; Yeh PY; Fan HH; Feng WC; Wang CT; Lin LI; Hsu C; Cheng AL
Cancer Res; 2010 Nov; 70(22):9309-18. PubMed ID: 21062976
[TBL] [Abstract][Full Text] [Related]
7. Triptolide inhibits viability and induces apoptosis in liver cancer cells through activation of the tumor suppressor gene p53.
Sun YY; Xiao L; Wang D; Ji YC; Yang YP; Ma R; Chen XH
Int J Oncol; 2017 Mar; 50(3):847-852. PubMed ID: 28098861
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of autophagy during ischemia-hypoxia and reperfusion in hepatocellular carcinoma.
Du H; Yang W; Chen L; Shen B; Peng C; Li H; Ann DK; Yen Y; Qiu W
Int J Oncol; 2012 Jun; 40(6):2049-57. PubMed ID: 22469951
[TBL] [Abstract][Full Text] [Related]
11. WP1130 increases doxorubicin sensitivity in hepatocellular carcinoma cells through usp9x-dependent p53 degradation.
Liu H; Chen W; Liang C; Chen BW; Zhi X; Zhang S; Zheng X; Bai X; Liang T
Cancer Lett; 2015 Jun; 361(2):218-25. PubMed ID: 25749422
[TBL] [Abstract][Full Text] [Related]
12. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
13. Regulation of apoptosis and autophagy by luteolin in human hepatocellular cancer Hep3B cells.
Lee Y; Kwon YH
Biochem Biophys Res Commun; 2019 Oct; 517(4):617-622. PubMed ID: 31383362
[TBL] [Abstract][Full Text] [Related]
14. Mcl-1 as a potential therapeutic target for human hepatocelluar carcinoma.
Yu Q; Liu ZY; Chen Q; Lin JS
J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):494-500. PubMed ID: 27465322
[TBL] [Abstract][Full Text] [Related]
15. Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling.
Lu WJ; Chua MS; So SK
Oncotarget; 2015 Dec; 6(39):41722-35. PubMed ID: 26497681
[TBL] [Abstract][Full Text] [Related]
16. Adenine inhibits growth of hepatocellular carcinoma cells via AMPK-mediated S phase arrest and apoptotic cascade.
Su WW; Huang JY; Chen HM; Lin JT; Kao SH
Int J Med Sci; 2020; 17(5):678-684. PubMed ID: 32210718
[No Abstract] [Full Text] [Related]
17. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of autophagic flux by salinomycin results in anti-cancer effect in hepatocellular carcinoma cells.
Klose J; Stankov MV; Kleine M; Ramackers W; Panayotova-Dimitrova D; Jäger MD; Klempnauer J; Winkler M; Bektas H; Behrens GM; Vondran FW
PLoS One; 2014; 9(5):e95970. PubMed ID: 24816744
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of carboplatin- and quercetin-induced cell death by roscovitine is Akt dependent and p53 independent in hepatoma cells.
Sharma A; Bhat MK
Integr Cancer Ther; 2011 Dec; 10(4):NP4-14. PubMed ID: 21994207
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway.
Wan Z; Pan H; Liu S; Zhu J; Qi W; Fu K; Zhao T; Liang J
Oncol Rep; 2015 Mar; 33(3):1560-6. PubMed ID: 25607597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]